US FDA Approves Covid-19 Drug of Lilly to be Taken Without Remdesivir
The pharmaceutical company ‘Lilly’ said that, the Food and Drug Administration (FDA) of the United States had widened the emergency use authorization for the baricitinib for the purpose of allowing it for the treatment of the novel corona virus with or without the remdesivir. The previous emergency use authorization had been restricted for using it […]
Continue Reading